Gain Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Gain Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q3 2024.
  • Gain Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $282K, a 42.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $282K -$209K -42.6% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $326K -$234K -41.8% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $384K -$226K -37% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $459K -$201K -30.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $491K -$180K -26.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $560K -$186K -25% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $610K -$221K -26.6% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $660K -$241K -26.8% Dec 31, 2022 10-K 2024-03-26
Q3 2022 $670K -$77.3K -10.3% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $746K -$66.5K -8.19% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $831K +$332K +66.6% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $901K +$378K +72.3% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $748K Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $812K Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $499K Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $523K Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.